Treatment for Acute Anxiety in Dementia
For acute anxiety in dementia, a stepped approach is recommended, starting with non-pharmacological interventions first, followed by short-term use of SSRIs if needed, with benzodiazepines reserved only for severe, acute episodes due to their significant risks. 1
First-Line: Non-Pharmacological Interventions
Non-pharmacological approaches should be attempted before medication:
- Identify and address underlying causes - Look for pain, discomfort, environmental triggers, or unmet needs that may be causing anxiety 1
- Music therapy - Most effective non-pharmacological intervention for anxiety in dementia 2
- Physical activity/exercise - Second most effective non-pharmacological approach 2
- Behavioral strategies - Use the "three R's" approach (repeat, reassure, and redirect) to manage anxiety episodes 1
- Environmental modifications - Reduce excess stimulation, maintain consistent routines, and provide a safe, familiar environment 1
- Cognitive behavioral therapy (CBT) - Modified CBT approaches have shown promise for anxiety in mild to moderate dementia 3
- Caregiver education - Teaching caregivers effective communication techniques and behavioral management strategies 1
Second-Line: Pharmacological Interventions
When non-pharmacological approaches are insufficient:
SSRIs (First-choice medications)
- Citalopram (Celexa) - Start at 10 mg daily, maximum 40 mg daily 1
- Sertraline (Zoloft) - Start at 25-50 mg daily, maximum 200 mg daily 1
- Paroxetine (Paxil) - Start at 10 mg daily, maximum 40 mg daily 1
SSRIs are preferred because:
- They significantly improve overall neuropsychiatric symptoms and agitation in dementia 1
- They have minimal anticholinergic side effects compared to other options 1
- They are considered first-line treatments for agitation in dementia 1
Non-Benzodiazepine Anxiolytics
- Buspirone (BuSpar) - Start at 5 mg twice daily, maximum 20 mg three times daily 1
- Only useful for mild to moderate agitation
- May take 2-4 weeks to become effective
- Less sedating than benzodiazepines
Third-Line (For Severe, Acute Episodes Only)
Benzodiazepines (Use with extreme caution)
- Lorazepam (Ativan), Oxazepam (Serax) - Short-acting agents preferred 1
- Important cautions:
- Use lowest possible dose for shortest duration (ideally less than 2 weeks) 4
- Significant risks in elderly dementia patients: sedation, cognitive impairment, falls, paradoxical agitation 1, 4
- Regular use leads to tolerance, addiction, and worsening cognitive impairment 1
- Beers Criteria recommends avoiding if possible in elderly patients 1
Medications to Avoid
- Antipsychotics - Both typical and atypical antipsychotics carry FDA black box warnings for increased mortality risk in dementia patients 1
- Anticholinergic medications - Worsen cognition and can increase confusion 1
- Long-acting benzodiazepines (e.g., diazepam) - Accumulate in elderly patients and increase risk of adverse effects 1, 4
Implementation Algorithm
- Assess for underlying causes (pain, infection, environmental factors)
- Implement non-pharmacological interventions (music therapy, exercise, behavioral strategies)
- If insufficient response after 1-2 weeks, consider SSRI (citalopram or sertraline)
- For severe, acute anxiety that poses immediate safety risk, short-term lorazepam may be considered while initiating other treatments
- Regularly reassess medication need and attempt gradual discontinuation when symptoms stabilize
Common Pitfalls to Avoid
- Rushing to medication before trying non-pharmacological approaches 1
- Using benzodiazepines as first-line treatment 1
- Continuing medications longer than necessary without reassessment 1
- Overlooking underlying causes of anxiety that could be addressed without medication 1
- Failing to recognize that anxiety in dementia is often existential in nature and related to loss 5